angiotensin ii has been researched along with tacrolimus in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 7 (36.84) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Golbaekdal, K; Nielsen, CB; Pedersen, EB | 1 |
| Ju, H; Liang, H; Marrero, MB; Venema, RC; Venema, VJ; Wang, X | 1 |
| Woo, KT | 1 |
| Eguchi, S; Frank, GD; Inagami, T; Motley, ED; Saito, S; Utsunomiya, H | 1 |
| Ichihara, S; Iwase, M; Izawa, H; Nagasaka, T; Nagata, K; Nakashima, N; Obata, K; Odashima, M; Somura, F; Yamada, Y; Yokota, M | 1 |
| Chester, AH; Hafizi, S; Proud, CG; Wang, X; Yacoub, MH | 1 |
| Finckenberg, P; Lindgren, L; Louhelainen, M; Luft, FC; Merasto, S; Mervaala, EM; Müller, DN; Vapaatalo, H | 1 |
| Li, J; Molenaar, P; Russell, FD; Wang, J | 1 |
| Chen, LM; Chu, CH; Huang, CY; Kuo, WW; Lee, SD; Lin, JA; Liu, CJ; Liu, JY; Lu, MC; Wu, CH | 1 |
| Arendshorst, WJ; Fellner, SK; Thai, TL | 1 |
| Ge, J; Gong, H; Li, L; Niu, Y; Sun, A; Wu, J; Zhou, N; Zou, Y | 1 |
| Montezano, AC; Touyz, RM; White, M | 1 |
| Axelsson, J; Rippe, A; Rippe, B; Sverrisson, K | 1 |
| Li, Y; Shengyou, Y; Yuanyuan, M; Zhihong, H | 1 |
| Liang, J; Liu, L; Wang, Z; Wen, Y; Zhang, Y; Zhou, P | 1 |
| Copits, BA; de Kloet, AD; Dussor, G; Gereau, RW; Haroutounian, S; Jain, S; Kadunganattil, S; Karlsson, P; Krause, EG; McIlvried, LA; Mickle, AD; Mohapatra, DP; Price, TJ; Ray, PR; Sheahan, TD; Shepherd, AJ; Tadinada, SM; Usachev, YM; Valtcheva, MV | 1 |
| Fujigaki, Y; Ishizawa, K; Li, J; Lifton, RP; Shibata, S; Tamura, Y; Uchida, S; Wang, Q; Yamazaki, O | 1 |
| Abeyat, H; Behmanesh, MA; Poormoosavi, SM; Sangtarash, E | 1 |
| Ali, FEM; Azouz, AA; Hersi, F; Hussein Elkelawy, AMM; Omar, HA | 1 |
1 review(s) available for angiotensin ii and tacrolimus
| Article | Year |
|---|---|
Current therapeutic strategies in glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cyclophosphamide; Cyclosporine; Dipyridamole; Glomerulonephritis; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Remission Induction; Steroids; Tacrolimus; Vasodilator Agents; Warfarin | 1999 |
18 other study(ies) available for angiotensin ii and tacrolimus
| Article | Year |
|---|---|
The acute effects of FK-506 on renal haemodynamics, water and sodium excretion and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide and vasopressin in pigs.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Immunosuppressive Agents; Injections, Intravenous; Kidney; Lithium; Random Allocation; Sodium; Swine; Tacrolimus; Vasopressins | 1996 |
Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Aorta; Calcineurin; Cells, Cultured; DNA-Binding Proteins; Enzyme Inhibitors; Janus Kinase 2; Muscle, Smooth, Vascular; Okadaic Acid; Oligonucleotides, Antisense; Phosphoprotein Phosphatases; Phosphorylation; Phosphotyrosine; Protein Phosphatase 2; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tacrolimus; Trans-Activators; Tyrphostins | 1999 |
Cyclosporin A inhibits angiotensin II-induced c-Jun NH(2)-terminal kinase activation but not protein synthesis in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Anisomycin; Aorta, Thoracic; Cells, Cultured; Cyclosporine; Enzyme Activation; Enzyme Inhibitors; Immunosuppressive Agents; JNK Mitogen-Activated Protein Kinases; Leucine; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Sulfonamides; Tacrolimus | 2002 |
AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcineurin; Cardiomegaly; Echocardiography; Fibrosis; Gene Expression Regulation; Hypertension; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; RNA, Messenger; Stress, Mechanical; Tacrolimus; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells.
Topics: Adaptor Proteins, Signal Transducing; Androstadienes; Angiotensin II; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Chromones; Coronary Vessels; Enzyme Inhibitors; Eukaryotic Initiation Factor-4E; Humans; Immunosuppressive Agents; Morpholines; Myocytes, Smooth Muscle; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Wortmannin | 2004 |
Magnesium supplementation prevents angiotensin II-induced myocardial damage and CTGF overexpression.
Topics: Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Connective Tissue Growth Factor; Dietary Supplements; Fibrosis; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Magnesium; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tacrolimus | 2005 |
Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II.
Topics: Adult; Angiotensin II; Blotting, Western; Calcineurin; Endothelin-1; Female; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Peptides; Phosphates; Protein Kinase C; Tacrolimus; Urotensins | 2005 |
Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
Topics: Angiotensin II; Animals; Antibodies; Apoptosis; bcl-Associated Death Protein; Calcineurin; Calcineurin Inhibitors; Caspase 3; Caspase 9; Caspases; Cell Line; Cyclosporine; Cytochromes c; DNA Fragmentation; Drug Synergism; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Models, Biological; Myoblasts, Cardiac; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptor, IGF Type 2; Signal Transduction; Tacrolimus; Transfection | 2006 |
ADP-ribosyl cyclase and ryanodine receptor activity contribute to basal renal vasomotor tone and agonist-induced renal vasoconstriction in vivo.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Angiotensin II; Animals; Calcium Channel Agonists; Immunosuppressive Agents; Kidney; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Norepinephrine; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Ryanodine Receptor Calcium Release Channel; Tacrolimus; Vasoconstriction; Vasomotor System | 2007 |
Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Chlorocebus aethiops; COS Cells; Losartan; Mice; Mice, Mutant Strains; Receptor, Angiotensin, Type 1; Stress, Mechanical; Tacrolimus | 2010 |
Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.
Topics: Angiotensin II; Animals; Calcineurin; Cell Proliferation; Cyclosporine; Fibroblasts; Immunosuppressive Agents; Inflammation; Mitogen-Activated Protein Kinases; Myocardium; Phosphorylation; Rats; Rats, Inbred WKY; Signal Transduction; Tacrolimus | 2012 |
Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcineurin Inhibitors; Chromatography, Gel; Cyclic N-Oxides; Epoprostenol; Ergocalciferols; Fluorescein-5-isothiocyanate; Free Radical Scavengers; Glomerular Filtration Rate; GTP Phosphohydrolases; Immunosuppressive Agents; Kidney Glomerulus; Male; Permeability; rac1 GTP-Binding Protein; Rats; Rats, Wistar; Reactive Oxygen Species; rho-Associated Kinases; Spin Labels; Tacrolimus; Thiourea | 2013 |
Influence of tacrolimus on podocyte injury inducted by angiotensin II.
Topics: Angiotensin II; Animals; Apoptosis; Blotting, Western; Cell Line; Cell Shape; Flow Cytometry; Gene Expression Regulation; Mice; Podocytes; Puromycin Aminonucleoside; RNA, Messenger; Tacrolimus; Time Factors; TRPC Cation Channels; TRPC6 Cation Channel | 2015 |
Effect of the knockdown of Cabin1 on p53 in glomerular podocyte.
Topics: Angiotensin II; Animals; Apoptosis Regulatory Proteins; Calcineurin; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Kidney Glomerulus; Nephrectomy; Podocytes; Rats; RNA, Small Interfering; Tacrolimus; Tumor Suppressor Protein p53; WT1 Proteins | 2016 |
Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Cell Communication; Cells, Cultured; Female; Ganglia, Spinal; Genes, Reporter; Humans; Hyperalgesia; Imidazoles; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuralgia; Neutrophil Activation; Oxidation-Reduction; Pyridines; Receptor, Angiotensin, Type 2; Sensory Receptor Cells; Skin; Tacrolimus; TRPA1 Cation Channel | 2018 |
Calcineurin dephosphorylates Kelch-like 3, reversing phosphorylation by angiotensin II and regulating renal electrolyte handling.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Calcineurin; Calcineurin Inhibitors; Carrier Proteins; Cullin Proteins; Gene Expression Regulation; Germ-Line Mutation; Humans; Hyperkalemia; Hypertension; Kidney; Kidney Tubules, Distal; Mice; Microfilament Proteins; Multiprotein Complexes; Phosphorylation; Protein Serine-Threonine Kinases; Renal Insufficiency; T-Lymphocytes; Tacrolimus; Ubiquitination | 2019 |
Evaluation of the Effect of Captopril and Losartan on Tacrolimus-induced Nephrotoxicity in Rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Creatinine; Epithelium; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Male; Peptidyl-Dipeptidase A; Rats; Renin-Angiotensin System; Tacrolimus | 2021 |
Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid/ERK/p38 MAPK and Nrf2/SOD3/GCLC signaling pathways.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Calcineurin Inhibitors; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Glutamate-Cysteine Ligase; Kidney Diseases; Male; NF-E2-Related Factor 2; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Superoxide Dismutase; Tacrolimus; Uric Acid; Xanthenes | 2022 |